99 related articles for article (PubMed ID: 9333124)
1. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis.
Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Koji T; Urayama S; Fujiyama K; Kiriyama T; Nakashima T; Nakane PK; Nagataki S
J Bone Miner Res; 1997 Oct; 12(10):1637-46. PubMed ID: 9333124
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells.
Nakashima T; Sasaki H; Tsuboi M; Kawakami A; Fujiyama K; Kiriyama T; Eguchi K; Ichikawa M; Nagataki S
Endocrinology; 1998 Apr; 139(4):2032-40. PubMed ID: 9528991
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
Urayama S; Kawakami A; Nakashima T; Tsuboi M; Yamasaki S; Hida A; Ichinose Y; Nakamura H; Ejima E; Aoyagi T; Nakamura T; Migita K; Kawabe Y; Eguchi K
J Lab Clin Med; 2000 Sep; 136(3):181-93. PubMed ID: 10985496
[TBL] [Abstract][Full Text] [Related]
4. Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells.
Abe Y; Kawakami A; Nakashima T; Ejima E; Fujiyama K; Kiriyama T; Ide A; Sera N; Usa T; Tominaga T; Ashizawa K; Yokoyama N; Eguchi K
J Lab Clin Med; 2000 Nov; 136(5):344-54. PubMed ID: 11079461
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts.
Kawakami A; Nakashima T; Tsuboi M; Urayama S; Matsuoka N; Ida H; Kawabe Y; Sakai H; Migita K; Aoyagi T; Nakashima M; Maeda K; Eguchi K
Biochem Biophys Res Commun; 1998 Jun; 247(1):46-51. PubMed ID: 9636651
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
7. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways.
Duque G; El Abdaimi K; Henderson JE; Lomri A; Kremer R
Bone; 2004 Jul; 35(1):57-64. PubMed ID: 15207741
[TBL] [Abstract][Full Text] [Related]
9. Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations.
Su X; Cheng J; Liu W; Liu C; Wang Z; Yang P; Zhou T; Mountz JD
J Immunol; 1998 Jun; 160(11):5288-93. PubMed ID: 9605126
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of 2-mercaptoethanol induces apoptosis in a B-cell line via Fas upregulation.
Neumann D; Zierke M; Martin MU
J Cell Physiol; 1998 Oct; 177(1):68-75. PubMed ID: 9731746
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
14. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
Kuo PL
Life Sci; 2005 Oct; 77(23):2964-76. PubMed ID: 15982670
[TBL] [Abstract][Full Text] [Related]
15. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
16. Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
Kuo PL; Huang YT; Chang CH; Chang JK
Int Immunopharmacol; 2006 Jul; 6(7):1167-75. PubMed ID: 16714221
[TBL] [Abstract][Full Text] [Related]
17. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
18. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
Büssing A; Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
20. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
